ACLU, PubPat Seek Supreme Court Review of Myriad Lawsuit | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The American Civil Liberties Union and the Public Patent Foundation have petitioned the US Supreme Court to hear their case against Myriad Genetics, which seeks to invalidate patents on the BRCA1 and BRCA2 genes that are licensed by Myriad.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.